Hospital microbiology laboratory practices for Enterobacteriaceae: Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN) annual survey, 2015 and 2016

Infect Control Hosp Epidemiol. 2018 Sep;39(9):1115-1117. doi: 10.1017/ice.2018.153. Epub 2018 Jul 24.

Abstract

We analyzed clinical microbiology laboratory practices for detection of multidrug-resistant Enterobacteriaceae in US short-stay acute-care hospitals using data from the National Healthcare Safety Network (NHSN) Annual Facility Survey. Half of hospitals reported testing for carbapenemases, and 1% performed routine polymyxin susceptibility testing using reference broth microdilution.

Publication types

  • Multicenter Study

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Carbapenems / pharmacology
  • Centers for Disease Control and Prevention, U.S.
  • Enterobacteriaceae / drug effects*
  • Enterobacteriaceae / isolation & purification
  • Humans
  • Laboratories, Hospital / statistics & numerical data*
  • Microbial Sensitivity Tests / statistics & numerical data*
  • Polymyxins / pharmacology
  • Surveys and Questionnaires
  • United States

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Polymyxins